Discover key trends, top players, and future forecasts driving the global Radionuclide Injection Market and is expanding at a CAGR of 10.04% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Radionuclide Injection Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Radionuclide Injection Market Revenue and Volume, By Application
8.1.1 Hospitals
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Clinics
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Dignostics Center
8.1.3.1. Market Revenue and Volume Forecast
9.1. Radionuclide Injection Market Revenue and Volume, By Type
9.1.1. Cancer
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Coronery Artery Disease
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Application
10.1.2. Market Revenue and Volume Forecast, By Type
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Application
10.1.3.2. Market Revenue and Volume Forecast, By Type
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Application
10.1.4.2. Market Revenue and Volume Forecast, By Type
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Application
10.2.2. Market Revenue and Volume Forecast, By Type
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Application
10.2.3.2. Market Revenue and Volume Forecast, By Type
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Application
10.2.4.2. Market Revenue and Volume Forecast, By Type
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Application
10.2.5.2. Market Revenue and Volume Forecast, By Type
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Application
10.2.6.2. Market Revenue and Volume Forecast, By Type
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Application
10.3.2. Market Revenue and Volume Forecast, By Type
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Application
10.3.3.2. Market Revenue and Volume Forecast, By Type
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Application
10.3.4.2. Market Revenue and Volume Forecast, By Type
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Application
10.3.5.2. Market Revenue and Volume Forecast, By Type
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Application
10.3.6.2. Market Revenue and Volume Forecast, By Type
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Application
10.4.2. Market Revenue and Volume Forecast, By Type
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Application
10.4.3.2. Market Revenue and Volume Forecast, By Type
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Application
10.4.4.2. Market Revenue and Volume Forecast, By Type
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Application
10.4.5.2. Market Revenue and Volume Forecast, By Type
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Application
10.4.6.2. Market Revenue and Volume Forecast, By Type
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Application
10.5.2. Market Revenue and Volume Forecast, By Type
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Application
10.5.3.2. Market Revenue and Volume Forecast, By Type
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Application
10.5.4.2. Market Revenue and Volume Forecast, By Type
11.1. GE HealthCare
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Cardinal Health
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Curium
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bayer AG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Bracco Imaging S.p.A.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Lantheus Holdings
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Siemens Healthineers
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Isotope JSC
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Jubilant Pharma
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Ntp Radioisotopes Soc Ltd.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample